Cadila Healthcare share price: BUY with price target of Rs 720, suggests Sharekhan
Brokerage firm Sharekhan says that Cadila Healthcare said that the company is making concentrated efforts to build a strong presence in areas of complex generics, injectable, and specialty portfolios in the US, which offer strong growth potential, which could unfold over the medium to long term. It recommends a buy on this stock with a target price of Rs 720
Cadila is progressing in its efforts to build a growth platform encompassing - New Chemical Entities (NCEs), biologics, vaccines, and specialty portfolio that could start delivering over the long term: Reuters